Clinical Trials and Research Study Opportunities
Health Research Unit
Do you have endometriosis or know someone who does?
Endometriosis is a condition where cells that normally line the uterus grow outside your uterus. The primary objective of this study is to evaluate the safety, tolerability, and efficacy of elagolix, administered once daily or twice
daily for 3 months in the management of moderate to severe endometriosis-associated pain, and to evaluate the effect of elagolix treatment on analgesic use for endometriosis-associated pain. Secondary efficacy objectives include
assessment of persistence of efficacy at 6 months, and assessments of other endometriosis-related symptoms, analgesic use, as well as quality of life endpoints.
The Women's Health Research Unit at OHSU is currently recruiting for a national clinical research study evaluating an investigational drug that may help reduce pain caused by endometriosis.
If you are a pre-menopausal woman between 18 and 49 years of age, do not have plans to become pregnant within the next twenty-five months, and have had a previous diagnosis of endometriosis, you may be eligible for study participation.
Please call our confidential recruitment line at 503-494-3666 to find out whether you may qualify for this study. Study participation will last up to twenty-five months. Study visits will include exams, blood tests, ultrasounds and study
medication at no cost. Participants also may be eligible for up to $2290 compensation for time and travel. Participants have a 43% chance of receiving placebo.
If you are affected by endometriosis and associated pain, or you know someone who is, please call 503-494-3666 for more information.
The Division of Women's Health Research
The Women's Health Research Unit at OHSU: Finding New Solutions to Old Problems